In this issue:
Vein-first ligation during lung cancer surgery: survival benefits
Atezolizumab cost in metastatic, nonsquamous NSCLC
Genes related to increased NSCLC brain metastases risk
CTC counts correlate with prognosis in advanced NSCLC
Risk of HBV reactivation during EGFR TKI therapy
BRAF mutation not a strong prognostic factor in NSCLC
PRO benefit with nivolumab + ipilimumab in NSCLC & high TMB
ICIs improve survival in NSCLC with leptomeningeal disease
Please login below to download this issue (PDF)